Treatment of post-covid erectile dysfunction is a matter for Erosil

Given the high incidence of coronavirus disease (COVID-19), men around the world are seeing the emergence of problems with sexual and reproductive health. This link is confirmed by numerous studies conducted in 2021 (1).

It turned out that endothelial dysfunction, subclinical hypogonadism, psychological distress and pulmonary hemodynamic disorders caused by viral infection contribute to the potential occurrence of erectile dysfunction.

For the treatment of such patients, the pharmaceutical company Astrapharm produces the drug Erosil. The drug helps men achieve and maintain an erection of the penis, necessary for successful sexual intercourse.

Sildenafil citrate, which is part of Erosil, is a selective antagonist of cGMP-specific phosphodiesterase 5 (PDE5) in the cavernous bodies. During sexual arousal, the drug restores reduced erectile function by increasing blood flow to the penis.

The maximum plasma concentration of the drug is reached within 30-120 minutes after oral administration on an empty stomach. However, onset of action can occur as early as 14 minutes in approximately 35% of patients (2). When using sildenafil during meals, the effect of Erosil slows down.

Among the advantages of the drug:

• highly effective and safe treatment of erectile dysfunction, regardless of the patient’s age (3);
• duration of sexual intercourse – from 30 minutes to 4-5 hours after taking;
• the effectiveness of the drug can be maintained up to 12 hours (4);
• the activity of spermatozoa increases (5);
• 4 weeks of treatment with sildenafil improves not only erectile function (as measured by IIEF-5), but also overall satisfaction with sexual activity, overall energy levels, mental performance and quality of life (6).

Erosil is available in the form of tablets containing 50 or 100 mg of sildenafil citrate, 1 or 2, or 4 tablets in a blister.

The drug is used exclusively on prescription and is dispensed by prescription.

Astrapharm is the art of helping people!

1 – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355084/
2 – https://www.nature.com/articles/ijir200833
3 –https://www.sciencedirect.com/science/article/abs/pii/S1743609516003209?via%3Dihub
4 – https://www.sciencedirect.com/science/article/abs/pii/S0302283804002362?via%3Dihub
5 – Sofikitis N, Miyagawa I. Secretory dysfunction of the male accessory genital glands due to prostatic infections and fertility: a selected review of literature. // Jp J Fertil Steril. 1991 Vol. 36. P. 690-699.
6 – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565360/